To determine the reliability of geometric (edge-detection) quantitative coronary angiographic analysis (QCA) of restenosis within a new Cordis tantalum stent, QCA and intracoronary ultrasound (ICUS) measurements were compared in both an experimental restenosis model and in the clinical follow-u imental series, PlexiglasTM of patients. In the experp R antom vessels with concentric stenosis channels ranging from 0.75 to 3.0 mm in diameter and with a reference diameter of 3.0 mm were imaged both before and after their insertion in tantalum stems. In the clinical series, the agreement of QCA and ICUS measurements were studied in 23 patients who had undergone coronary implantation of the new tantalum stent and in 23 patients who had undergone balloon angioplasty 6 months previously. The reliability of QCA declined in the resence of the radiopaque stent (accuracy of QCA B ecreased from -0.07 to 4.12 mm), whereas the reliability of lumen measurements by ICUS was independent of the presence of the radiopaque stent (-0.12 and -0.13 mm). Without the stent, the avera e minimal luminal diameter (MLD) obtained by QCA o 9 the 1 .OO mm Plexiglas vessel was 1.00 + 0.01 mm, and the 3.00 mm reference vessel diameter was 2.81 & 0.05 mm, providin a 64 rt: 1% diameter stenosis. After introduction of ii e stent, the average MID and reference vessel diameter were 0.99 f: 0.06 and 3.36 f 0.17 mm, respectively, providing a diameter stenosis of 71 f 2%. ICUS measurements (2.77 mm) of the reference vessel diameter (3.00 mm) were unaffected by the presence of the stent. Agreement of ICUS and QCA measurements (ICUS -QCA) was poorer in patients who had undergone balloon angioplasty (0.68 + 0.42 mm) than in patients who had stent implantation (-0.05 + 0.42 mm). In the 6-month follow-up of patients who had undergone implantation of a highly radiopaque Cordis tantalum stent, assessment of restenosis was reliably quantified by QCA with the use of the MID rather than the percent diameter stenosis. Although ICUS measurements are unaffected by the radiopa d ue stent, the mechanical problem of ICUS catheter w ging in stenoses of e1.00 mm and the substantial cost of ICUS catheters will restrict the widespread application of ICUS for the assessment of intrastent restenosis.
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CORONARY ARTERY DISEASE/NEW RADIOPAQUE TANTALUM STENT 1135 W hereas most of the available coronary stents are of low or moderate radiopacity,14 a new helical coil stent composed of crenulated 0.005inch tantalum wire (Cordis, Miami, Florida) is highly radiopaque. Although during the interventional procedure itself, the strong radiopacity of tantalum stents facilitates the precise positioning of the stent in the target lesion and the subsequent placement of additional noncompliant balloons for high-pressure intrastent inflations, the radiopaque stent struts may interfere with the quantitative assessment of restenosis within the stent at angiographic follow-up. 5 The stenosis phantoms were produced at the workshop of Erasmus University, Rotterdam, The Netherlands. For the in vitro assessment of restenosis measurements within a new radiopaque stent, phantom vessels were filmed before and after their insertion in new balloon-expanded tantalum stents of 3.5 mm nominal diameter (see Figure 1 ). Phantom vessels were composed of radiolucent Plexiglas cylinders (35 mm in length, 3.6 mm in outer diameter) with precision-drilled concentric circular lumens of 0.75, 1.0, 1.25, 1.5, 2.0, 2.5, and 3.0 mm in diameter.7-9 The length of each phantom stenosis channel was 5 mm and the adjacent "normal refer- Afterpredilatation, a new radiopaque coronary Cordis stent was implanted in 23 lesions of 23 patients at Kokura Memorial Hospital, Kitakyushu, Japan. Twenty-one stents were implanted in 21 lesions of 21 patients and 4 stents were deployed in 2 lesions of 2 patients (2 stents in each lesion). Of the 25 stents used in 23 lesions, 14 stents were 3.0 mm and 11 were 3.5 mm in diameter. Of the 23 lesions, 11 were in the left anterior descending coronary artery, 5 in the left circumflex coronary artery, and 7 in the right coronary artery. Follow-up angiographic and ICUS examinations were performed at 6 f 1 months after stent implantation. The number and location of lesions were identical in the balloon angioplasty and stent implantation groups.
CLINICAL ANGIOGRAPHIC IMAGE ACQ~SITION AT 6-MONTHFOLLOW-UP:~~X-KIOU~~~O~~O~-U~ coronaryangiography was performed after the administration of intracoronary isosorbide dinitrate"v12 before manual injection of contrast medium (Iopamidol370; 370 mg iodine/ml) at 37°C. The 5-inch field-of-image intensifier was selected and the radiographic settings were kept constant (kV, mA, x-ray pulse width) in each projection. All clinical -images were acquired on 35 mm cinefilm at a frame rate of 25 images/s. An average of 2.6 cineframes/patient was selected for quantitative angiographic analysis. Minimal luminal diameter (MLD), reference vessel diameter, and luminal dimension at the proximal and distal extremities of the radiopaque stent were measured. Quantitatiie angiographic analysis: Cinefilms from both the experimental and clinical series were quantitatively analyzed using a computer-based Cardiovascular Angiographic Analysis System (CAAS II; Pie Medical, Maastricht, The Netherlands).7-9,12-17 Before performance of the calibration and analyses of the stenoses, computerized correction for pincushion distortion was applied by the recording and subsequent off-line digitization of a centimeter grid placed in front of the image intensifier in each cardiac catheterization laboratory. For both the experimental and clinical angiograms, quantitative measurements were calibrated by the use of the recorded contrast-free catheter tip as a scaling device. 18 The nontapering catheter tip was measured with a precision micrometer (no. 293-501, Mitutoyo, Tokyo, Japan; accuracy 0.001 mm). In the experimental study, a sufficiently long segment of the Plexiglas cylinders, including the phantom stenosis with or without the stent, was selected for analysis. In the clinical study, frames without foreshortening or overlapping side branches were selected.19 Arterial dimensions of clinical frames were measured at specific distances from identifiable branch points in end-diastolic frames.
In the CAAS II system: the entire cineframe of size 18 X 24 mm is digitized at a resolution of 1,329 X 1,772 pixels. In the CAAS system, the edge-detection algorithm is based on the first and second derivative functions applied to the digitized brightness profile along scanlines perpendicular to a model using minimal cost criteria. l6 A computer-derived estimation of the original dimensions of the vessel at the site of the obstruction was used to determine the interpolated reference vessel diameter. If the automatically detected contour did not faithfully track the border of the lumen, the level of the light-emitting diode, which regulated the image brightness during digitization of the cineframe, .was changed. Manual correction of the automatically detected contours was not performed in either the experimental phantom or the clinical studies. MLD and reference diameter were quantified in multiple averaged views.
image acquisition of intracoronaty ultrasound: After selective coronary angiography, a mechanical ICUS imaging catheter (30 MHz, 2.9Fr, Cardiovascular Imaging Systems, Sunnyvale, California) was introduced over a 0.016inch guidewire. In the experimental series, a slow manual pullback was performed to assess the luminal dimension at the site of stenosis. In the clinical series, after the imaging catheter was passed into and beyond the lesion, a motorized pullback (Cardiovascular Imaging Systems) with a constant speed of 0.5 mm/s was begun to obtain an initial assessment of the target lesion. A simultaneous fluoroscopic image of the position of the ICUS catheter tip was continuously displayed. Side branches and stent struts visible on both the ultrasound and angiographic images served as reference points to ensure that the coronary sites of ultrasound and quantitative angiographic analysis were identical. ICUS images were stored on super VHS videotape for subsequent analysis.
Quantitatiie assessment of intracoronaty ultrasound:
The luminal area was defined as the integrated area central to the intimal leading-edge echo. Images with min- determine the interobserver variability of ICUS measurements, 30 lesions were independently measured by 2 observers. The mean signed difference and correlation of the measurements of cross-sectional area were 0.02 + 0.37 mm2 and 0.97, respectively. Statistical analysis: In the experimental study, the mean of the signed differences between the true phantom diameters and the individual MLD values derived from measurements of QCA and ICUS was considered an index of accuracy, and the SD of the differences was considered an index of precision. In the clinical study, the mean of: SD of the signed differences between measurements of MLD derived from QCA and from ICUS were used as an index of agreement between measurements. 20 The reliability of QCA, however, declined in the presence of the radiopaque stent (accuracy of QCA decreased from -0.07 to -0.12 mm), whereas the reliability of lumen measurements by ICUS was independent of the presence of the radiopaque stent (-0.12 and -0.13 mm before and after introduction of the stent, respectively). vessel with and without the new radiopaque stent can be seen in Figure 5 . ICUS measurements (2.77 mm) of the reference vessel diameter (3.00 mm) were unaffected by the presence of the stent. Clinical series: The results of measurements of MLD by ICUS are plotted against those by QCA for patients who had balloon angioplasty and those who had coronary stents in Figures 6A and 6B, To ensure that the differences between QCA and ICUS measurements of the minimal lumen diameter were not related to analysis at different locations in the stented coronary segment by ICUS and QCA, measurements were also compared at the proximal and distal extremities of the stem, which were clearly identifiable during both QCA and ICUS analysis. The results of measurements of the luminal dimension at the proximal and distal extremity of each radiopaque stent (46 measurements) by ICUS are plotted against those by QCA in Figure 7 . Agreement between the 2 sets of measurements at the extremity of the stent was -0.06 f 0.42 mm (mean + SD of the signed differences), and was associated with a correlation coefficient of 0.63. An example of angiographic measurement of the MLD of a patient with a new radiopaque stent at 6-month follow-up can be seen in Figure 8 .
RESULTS

DISCUSSION
The principal findings of our study are: (1) In the Plexiglas restenosis model, QCA provided more accurate measurements of MLD than ICUS. (2) After introduction of the Plexiglas vessel in the radiopaque stent, the accuracy of QCA declined, whereas the accuracy of ICUS measurements of both the MLD and the reference vessel diameter was unaffected by the radiopaque stent. (3) Measurements by QCA of the interpolated reference vessel diameter of the Plexiglas vessel were rendered inaccurate by the presence of the radiopaque stent and resulted in overestimation of the severity of the percent diameter stenosis. (4) In the 6-month follow-up of patients after coronary intervention, agreement of ICUS and QCA measurements was higher in patients who underwent stent implantation than in those who underwent balloon angioplasty alone. Limitation of quantitative coronary angiographic analysis: During QCA of the MLD within a stented vessel segment, the automated edge-detection algorithm will trace the true diameter of the contrast-filled lumen at the point FIGURE 5 . The contrast-filled lumen of the Plexiglas vessel is shown without insertion of the vessel within the radiopaque stent (right panel). Automated fully track the contour of the stenotic segment in both the absence and an ra 1 iographic analysis of the normal reference vessel diameter, however, was signi ropaque stent, with undulations and evident tracking out to include the contour edge of the contrast filled lumen. The maximal diameter was found to be 3.77 mm after introduction of the stem. Overestimation of the reference vessel diameter in the presence of the stent resulted in an exaggeration of the severity of the percent diameter stenosis.
CORONARY
ARTERY DISEASE/NEW RADIOPAQUE TANTALUM STENTof most severe stenosis in between the radiopaque stent struts (i.e., in the interstrut intervals). QCA of the MLD will thus remain reliable for 2 reasons: First, at 6-month follow-up in the presence of significant intimal hyperplasia, the outer edge of the radiopaque stent struts will be deeply embedded in the vessel wall at an adequate distance from the border of the contrast-filled true lumen and will thus not interfere with the automated edgedetection process. Second, the measurement is based on a very limited segment of the coronary lumen (according to the degree of smoothing or minimal cost criteria), which is shorter in length than the gap between successive radiopaque stent struts. However, during' measurement of the interpolated reference vessel diameter, QCA by automated edge detection may be unreliable for 2 reasons: First, beyond the subsegment of maximal restenosis, the outer contour of the radiopaque stent struts lies in close proximity to the border of the true lumen and may therefore interfere with the automated edge detection, which may be unable to differentiate the outer contours of the lumen and stent struts. Second, the interpolated reference vessel diameter is based on multiple scanlines over a large extent of the analyzed segment, which will incorporate both scanlines that do and do not include the outer contour of the radiopaque stent struts.
Rather than using a subjective operator-selected reference point, the default mode of the CAAS system determines the size at the target coronary segment using an objective computer-derived interpolated reference diameter.7-gJ2-'7 The interpolated reference diameter is derived from the edge-detected diameter function of the nonstenotic proximal -and distal subsegments. The reference vessel diameter values are estimated by fitting a straight line to the diameter function proximal and distal to the obstruction, followed by' a shift so that 80% of the diameter values are below the adjusted straight line. This line then represents the reconstructed reference diameter function and gives an estimate of the arterial size at each point along the analyzed coronary segment. The interpolated reference vessel diameter is taken as the value 'of the reconstructed diameter function at the position of the MLD. The advantages of this approach are that it is essentially user-independent and thus highly reproducible, and every measurement is based on multiple measurements (every scanline) proximal and distal to the lesion. The limitation of this technique is in ostial lesions where a proximal segment is unavailable and, in the case of this new highly radiopaque tantalum stent, where selection of a reference point either proximal or distal to the-new Cordis tantalum stent (or an average of both) may prevent overestimation of vessel size associated with use of the default-interpolated reference vessel diameter mode.
Although not directly addressed by our study, it should be acknowledged that interference with the reliability of QCA by this new radiopaque stent may also occur immediately after stent implantation, and thus similar precautions in the application of QCA should be applied.
limitations of iniracoronary ultrasound: ICUS can provide clinically useful information on lesion and vessel characterization as well as on guidance of optimal stent deployment.27-30 However, the 2.9Fr size of the ultrasound catheter restricts application of ICUS for lumen quantification to lesions of >l.O mm in diameter because of mechanical wedging of the catheter. In our study, 3 of 23 stented lesions and 8 of the 23 lesions previously treated with balloon angioplasty showed signs of catheter wedging, and these measurements were therefore excluded from analysis. Thus, although ICUS may be useful immediately after intervention for assessment of stent deployment, by 6-month follow-up lesions with significant restenosis may be unsuitable for ICUS evaluation. Furthermore, because the price of ultrasound catheters remains expensive (approximately $1,300), it is difficult to justify the use of ICUS for routine followup of all stented patients.
Derivation of the MLD by ICUS measurement of the minimal luminal cross-sectional area (7cr2) inherently assumes a circular lumen, which may not be appropriate in the presence of severely eccentric atherosclerotic disease. Our use of a symmetric lumen in our phantom vessel allowed measurement by ICUS of the MLD to be obtained by either direct diameter measurement or by derivation from the minimal luminal cross-sectional area (Tr2). The ratio of the 2 derived diameters in our stent and balloon angioplasty series was 0.89 f 0.08 and 0.82 + 0.08, respectively, consistent with a relatively symmetric lumen morphology at 6-month follow-up.
Given the unique inherent limitations of both ICUS and QCA techniques, the observation of a difference in their measurements in the absence of the known true diameter does not permit a conclusion on the absolute accuracy of either technique. We therefore included a phantom restenosis model with known internal dimensions to provide a measure of accuracy of both techniques .
Implications: For patients undergoing 6-month angiographic follow-up of this new radiopaque Cordis stent, measurements by QCA of the MLD may be performed reliably. When a QCA system is used that offers a default-interpolated reference vessel diameter mode, the reference vessel diameter of the stented segment may be overestimated and thus the severity of the percent diameter stenosis 'may also be overestimated, unless a manually selected reference point(s) proximal and/or distal to the Cordis tantalum stent is used. Alternatively, for determination of relative loss (absolute loss in MLD normalized for vessel size), the interpolated reference vessel diameter measured before intervention may be used.
At the time of stent implantation, and thus before the development of intimal hyperplasia, the stent struts will be in apposition to the vessel wall and thus the outer contour of the radiopaque stent struts should be coincident with the outer contour of the contrast-filled lumen. At this procedural phase, we do not find in clinical practice that the radiopacity of the stent struts interfere with on-line QCA during stent deployment. Thus, determination of the absolute (MLD post -MLD pre) and relative (MLD post -MLD pre normalized for reference vessel diameter pre) gain achieved at stent implantation, the absolute (MLD post -MLD follow-up) and relative (MLD post -MLD follow-up normalized for reference vessel diameter pre) loss in MLD over 6 months, and the loss index (loss/gain) (restenosis process), as well as measurement of the absolute MLD at follow-up (final outcome), should be feasible with QCA in patients undergoing implantation of this tantalum stent. 
